Clinical outcomes of implantable cardioverter-defibrillator therapy in noncompaction cardiomyopathy: a systematic review and meta-analysis
- PMID: 35689132
- PMCID: PMC9902401
- DOI: 10.1007/s10741-022-10250-w
Clinical outcomes of implantable cardioverter-defibrillator therapy in noncompaction cardiomyopathy: a systematic review and meta-analysis
Abstract
A subgroup of patients with noncompaction cardiomyopathy (NCCM) is at increased risk of ventricular arrhythmias and sudden cardiac death (SCD). In selected patients with NCCM, implantable cardioverter-defibrillator (ICD) therapy could be advantageous for preventing SCD. Currently, there is no complete overview of outcome and complications after ICD therapy in patients with NCCM. This study sought to present an overview using pooled data of currently available studies. Embase, MEDLINE, Web of Science, and Cochrane databases were searched and returned 915 studies. After a thorough examination, 12 studies on outcome and complications after ICD therapy in patients with NCCM were included. There were 275 patients (mean age 38.6 years; 47% women) with NCCM and ICD implantation. Most of the patients received an ICD for primary prevention (66%). Pooled analysis demonstrates that the appropriate ICD intervention rate was 11.95 per 100 person-years and the inappropriate ICD intervention rate was 4.8 per 100 person-years. The cardiac mortality rate was 2.37 per 100 person-years. ICD-related complications occurred in 10% of the patients, including lead malfunction and revision (4%), lead displacement (3%), infection (2%), and pneumothorax (2%). Patients with NCCM who are at increased risk of SCD may significantly benefit from ICD therapy, with a high appropriate ICD therapy rate of 11.95 per 100 person-years and a low cardiac mortality rate of 2.37 per 100 person-years. Inappropriate therapy rate of 4.8 per 100 person-years and ICD-related complications were not infrequent and may lead to patient morbidity.
Keywords: Appropriate ICD treatment; Implantable cardioverter-defibrillator (ICD); Mortality; Noncompaction cardiomyopathy; Sudden cardiac death; Systematic review and meta-analysis.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270. Health Technol Assess. 2006. PMID: 16904046
-
Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.Circ Heart Fail. 2012 Sep 1;5(5):552-9. doi: 10.1161/CIRCHEARTFAILURE.112.969626. Epub 2012 Jul 20. Circ Heart Fail. 2012. PMID: 22821634
-
Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.Heart Rhythm. 2016 Feb;13(2):443-54. doi: 10.1016/j.hrthm.2015.09.010. Epub 2015 Sep 15. Heart Rhythm. 2016. PMID: 26385533
-
Recurrent ventricular arrhythmias and mortality in cardiac arrest survivors with a reversible cause with and without an implantable cardioverter defibrillator: A systematic review.Resuscitation. 2022 Apr;173:76-90. doi: 10.1016/j.resuscitation.2022.02.019. Epub 2022 Feb 25. Resuscitation. 2022. PMID: 35227821
-
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.Circulation. 2025 Jan 28;151(4):322-332. doi: 10.1161/CIRCULATIONAHA.124.071795. Epub 2024 Sep 26. Circulation. 2025. PMID: 39327797 Free PMC article. Clinical Trial.
Cited by
-
Sudden cardiac arrest mortality in China: temporal trends and risk factors.Mil Med Res. 2025 Aug 15;12(1):49. doi: 10.1186/s40779-025-00639-7. Mil Med Res. 2025. PMID: 40813723 Free PMC article.
References
-
- Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R (2002) Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 36:493–500, Aug 2000. 10.1016/s0735-1097(00)00755-5 - PubMed
-
- Caliskan OISK, ten Cate FJ, editors. Noncompaction cardiomyopathy. Cham: Springer; 2019.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical